Cargando…
PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429456/ http://dx.doi.org/10.1097/01.HS9.0000975288.42582.76 |
| _version_ | 1785090717783162880 |
|---|---|
| author | Manteca, Maria Victoria Mateos Grosicki, Sebastian Kim, Kihyun Negre, Eric Vandendries, Erik |
| author_facet | Manteca, Maria Victoria Mateos Grosicki, Sebastian Kim, Kihyun Negre, Eric Vandendries, Erik |
| author_sort | Manteca, Maria Victoria Mateos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429456 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294562023-08-17 PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Manteca, Maria Victoria Mateos Grosicki, Sebastian Kim, Kihyun Negre, Eric Vandendries, Erik Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429456/ http://dx.doi.org/10.1097/01.HS9.0000975288.42582.76 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Manteca, Maria Victoria Mateos Grosicki, Sebastian Kim, Kihyun Negre, Eric Vandendries, Erik PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title | PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_full | PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_fullStr | PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_full_unstemmed | PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_short | PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_sort | pb2131: magnetismm-7: an open-label, multicenter, randomized phase 3 study of elranatamab versus lenalidomide in post-transplant patients with newly diagnosed multiple myeloma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429456/ http://dx.doi.org/10.1097/01.HS9.0000975288.42582.76 |
| work_keys_str_mv | AT mantecamariavictoriamateos pb2131magnetismm7anopenlabelmulticenterrandomizedphase3studyofelranatamabversuslenalidomideinposttransplantpatientswithnewlydiagnosedmultiplemyeloma AT grosickisebastian pb2131magnetismm7anopenlabelmulticenterrandomizedphase3studyofelranatamabversuslenalidomideinposttransplantpatientswithnewlydiagnosedmultiplemyeloma AT kimkihyun pb2131magnetismm7anopenlabelmulticenterrandomizedphase3studyofelranatamabversuslenalidomideinposttransplantpatientswithnewlydiagnosedmultiplemyeloma AT negreeric pb2131magnetismm7anopenlabelmulticenterrandomizedphase3studyofelranatamabversuslenalidomideinposttransplantpatientswithnewlydiagnosedmultiplemyeloma AT vandendrieserik pb2131magnetismm7anopenlabelmulticenterrandomizedphase3studyofelranatamabversuslenalidomideinposttransplantpatientswithnewlydiagnosedmultiplemyeloma |